Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: a model for solid-cancer initiation and early development
- PMID: 24828886
- DOI: 10.1002/ijc.28975
Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: a model for solid-cancer initiation and early development
Abstract
A number of proposals have been made in the past century regarding what may drive sporadic cancers to initiate and develop. Yet the problem remains largely unsolved as none of the proposals have been widely accepted as cancer-initiation drivers. We propose here a driver model for the initiation and early development of solid cancers associated with inflammation-induced chronic hypoxia and reactive oxygen species (ROS) accumulation. The model consists of five key elements: (i)human cells tend to have a substantial gap between ATP demand and supply during chronic hypoxia, which would inevitably lead to increased uptake of glucose and accumulation of its metabolites; (ii) the accumulation of these metabolites will cast mounting pressure on the cells and ultimately result in the production and export of hyaluronic acid; (iii) the exported hyaluronic acid will be degraded into fragments of various sizes, serving as tissue-repair signals, including signals for cell proliferation, cell survival and angiogenesis, which lead to the initial proliferation of the underlying cells; (iv) cell division provides an exit for the accumulated glucose metabolites using them towards macromolecular synthesis for the new cell, and hence alleviate the pressure from the metabolite accumulation; and (v) this process continues as long as the hypoxic condition persists. In tandem, genetic mutations may be selected to make cell divisions and hence survival more sustainable and efficient, also increasingly more uncontrollable. This model also applies to some hereditary cancers as their key mutations, such as BRCA for breast cancer, generally lead to increased ROS and ultimately to repression of mitochondrial activities and up-regulation of glycolysis, as well as hypoxia; hence the energy gap, glucose-metabolite accumulation, hyaluronic acid production and continuous cell division for survival.
Keywords: Warburg effect; cancer resistance species; carcinogenesis; hyaluronic acid; hypoxia; reactive oxygen species.
© 2014 UICC.
Similar articles
-
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Mol Aspects Med. 2010. PMID: 20206201 Review.
-
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.Biochim Biophys Acta. 2016 Aug;1857(8):1086-1101. doi: 10.1016/j.bbabio.2016.03.012. Epub 2016 Mar 10. Biochim Biophys Acta. 2016. PMID: 26971832 Review.
-
The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression.Oxid Med Cell Longev. 2016;2016:3907147. doi: 10.1155/2016/3907147. Epub 2015 Dec 20. Oxid Med Cell Longev. 2016. PMID: 26798421 Free PMC article. Review.
-
Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.Semin Oncol. 2014 Apr;41(2):195-216. doi: 10.1053/j.seminoncol.2014.03.002. Epub 2014 Mar 5. Semin Oncol. 2014. PMID: 24787293 Review.
-
Mitochondrial supercomplex assembly promotes breast and endometrial tumorigenesis by metabolic alterations and enhanced hypoxia tolerance.Nat Commun. 2019 Sep 11;10(1):4108. doi: 10.1038/s41467-019-12124-6. Nat Commun. 2019. PMID: 31511525 Free PMC article.
Cited by
-
Membranous NOX5-derived ROS oxidizes and activates local Src to promote malignancy of tumor cells.Signal Transduct Target Ther. 2020 Aug 14;5(1):139. doi: 10.1038/s41392-020-0193-z. Signal Transduct Target Ther. 2020. PMID: 32792487 Free PMC article.
-
The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):211-218. doi: 10.21873/cgp.20032. Cancer Genomics Proteomics. 2017. PMID: 28647695 Free PMC article. Review.
-
Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.Front Cell Dev Biol. 2018 May 8;6:48. doi: 10.3389/fcell.2018.00048. eCollection 2018. Front Cell Dev Biol. 2018. PMID: 29868579 Free PMC article. Review.
-
Cancer microenvironment and inflammation: role of hyaluronan.Front Immunol. 2015 Apr 14;6:169. doi: 10.3389/fimmu.2015.00169. eCollection 2015. Front Immunol. 2015. PMID: 25926834 Free PMC article. Review.
-
Free Radical Scavenging Activity and Inhibition of Enzyme-Catalyzed Oxidation by trans-aryl-Palladium Complexes.Molecules. 2025 Feb 28;30(5):1122. doi: 10.3390/molecules30051122. Molecules. 2025. PMID: 40076345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous